These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6119876)

  • 1. Beta blockade and the secondary prevention of myocardial infarction.
    Hampton JR
    Acta Med Scand Suppl; 1981; 651():219-26. PubMed ID: 6119876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of beta blockers for the reduction of mortality after myocardial infarction.
    Hampton JR
    Eur Heart J; 1981 Aug; 2(4):259-68. PubMed ID: 6117465
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic beta blockade therapy in patients after myocardial infarction.
    Pratt CM; Roberts R
    Am J Cardiol; 1983 Oct; 52(7):661-4. PubMed ID: 6137945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 12. Beta-adrenoceptor blockade in myocardial infarction: the continuing controversy.
    Frishman WH
    Am Heart J; 1980 Apr; 99(4):528-36. PubMed ID: 6102436
    [No Abstract]   [Full Text] [Related]  

  • 5. Secondary prevention with beta-adrenoceptor blockers in post-myocardial infarction patients.
    Staessen J; Bulpitt C; Cattaert A; Fagard R; Vanhees L; Amery A
    Am Heart J; 1982 Dec; 104(6):1395-9. PubMed ID: 6128918
    [No Abstract]   [Full Text] [Related]  

  • 6. Beta blockers after myocardial infarction--aspects on study design based on current knowledge.
    Vedin A; Wilhelmsson C
    Acta Med Scand Suppl; 1981; 651():227-33. PubMed ID: 6119877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenergic blockade for survivors of acute myocardial infarction.
    Frishman WH; Furberg CD; Friedewald WT
    N Engl J Med; 1984 Mar; 310(13):830-7. PubMed ID: 6142420
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preventive effects of beta-blockers on myocardial infarction and on cardiac accidents following a first infarct].
    Fanchamps A
    Nouv Presse Med; 1978 Sep; 7(31):2741-5. PubMed ID: 30954
    [No Abstract]   [Full Text] [Related]  

  • 9. Beta-blockers after myocardial infarction.
    Med Lett Drugs Ther; 1979 Dec; 21(25):101. PubMed ID: 44732
    [No Abstract]   [Full Text] [Related]  

  • 10. Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol. A multicentre international study.
    Br Med J; 1975 Sep; 3(5986):735-40. PubMed ID: 240481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of beta-blockers after myocardial infarction.
    Turi ZG; Braunwald E
    JAMA; 1983 May; 249(18):2512-6. PubMed ID: 6133014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reduction of mortality in acute myocardial infarction in patients treated with alprenolol. Preliminary results].
    Andersen M; Bechsgaard P; Frederiksen J; Hansen DA; Jürgensen HJ; Nielsen PB; Pedersen F; Pedersen-Bjergaard O; Rasmussen SL
    Ugeskr Laeger; 1979 Nov; 141(45):3083-6. PubMed ID: 43001
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of long term beta-blockade after myocardial infarction: Paper 3.
    Wilkinson RK
    Aust Fam Physician; 1978 Jun; Suppl():38-9. PubMed ID: 30443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenergic blocking agents in prevention of sudden death.
    Chamberlain DA
    Adv Cardiol; 1978; 25():196-205. PubMed ID: 30260
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of beta-adrenoreceptive antagonists on the morbidity and mortality in cardiovascular disease.
    Fitzgerald JD
    Postgrad Med J; 1976 Dec; 52(614):770-81. PubMed ID: 13355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics].
    Schröder R
    Dtsch Med Wochenschr; 1981 Apr; 106(17):546-53. PubMed ID: 6111439
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials?
    Otterstad JE; Ford I
    Eur J Heart Fail; 2002 Aug; 4(4):501-6. PubMed ID: 12167391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta blocking agents: current status in the prevention of sudden coronary death.
    Hjalmarson A
    Ann N Y Acad Sci; 1982; 382():305-23. PubMed ID: 6123286
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-blockers and myocardial infarction: infarction and ischaemia in the practolol and propranolol trials.
    Green KG; Baber NS; Lewis JA
    Aust N Z J Med; 1983 Apr; 13(2):181-2. PubMed ID: 6137206
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute intervention studies in patients with myocardial infarction using atenolol, propranolol, oxprenolol and disopyramide phosphate.
    Wilcox RG
    Acta Med Scand Suppl; 1981; 651():193-202. PubMed ID: 6119875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.